Evidence map›Paper›PMID 2550801›Full record

ArticleMolecular and cellular biology1989

Hematopoietic lineage-specific heterogeneity in the 5'-terminal region of the chicken proto-myb transcript.

W K Kim, M A Baluda

Abstract readComparative Study
In one paragraph

Article in Molecular and cellular biology, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

W K KimDepartment of Pathology, School of Medicine, University of California, Los Angeles 90024.
M A Baluda
University of California, Los Angeles · US

Funding

TUMOR INDUCTION BY AVIAN MYELOBLASTOSIS VIRUSR01CA010197 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BALUDA, MARCEL A. · 1985 to 1993
–
NCI NIH HHS CA 10197
6 · The paper itself

Abstract

Comparison of the nucleotide sequence of the upstream c-myb exon UE3 with the sequences of a thymus c-myb cDNA and of a B-lymphoma c-myb cDNA suggested the existence of T- and B-cell-specific heterogeneity in the 5'-terminal region of the c-myb coding sequence. This possibility was investigated with T-cell-specific and B-cell-specific DNA probes in a Northern (RNA) blot analysis of mRNAs from different hematopoietic cell types and from chicken embryo fibroblasts. The hematopoietic tissues analyzed were bone marrow, bursa of Fabricius, and thymus from 1-day-old chicks, 13-day yolk sac, and spleen from 16-day embryos. At least three different c-myb mRNA species were found to have 5'-terminal heterogeneity that was specific for either B cells, T cells, or the other hematopoietic cells and chicken embryo fibroblasts. This lineage-specific heterogeneity in the c-myb transcript was found to be expressed in the bone marrow precursors of B and T cells before they migrated to their definitive differentiation sites. S1 nuclease protection analysis of the UE3 exon, part of which appeared to be coding sequences for thymic c-myb mRNA, revealed that this exon is utilized either in its entirety or partially in a cell-lineage-specific manner by all six tissues analyzed. Also, the 5'-terminal exon(s) present in the thymus cDNA was absent in c-myb mRNAs from the other cell types analyzed.

Indexed as

Proto-OncogenesAnimalsB-LymphocytesDNADNA ProbesEndonucleasesExonsHematopoietic SystemRNA, MessengerSequence Homology, Nucleic AcidSingle-Strand Specific DNA and RNA EndonucleasesTissue DistributionT-LymphocytesTranscription, GeneticDNADNA ProbesEndonucleasesRNA, MessengerSingle-Strand Specific DNA and RNA Endonucleases

Identifiers

PMID2550801
PMCPMC362438
OpenAlexW2134042223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.